Product
UC-MSC
4 clinical trials
6 indications
Indication
KeloidIndication
Stem CellIndication
Left Ventricular DysfunctionIndication
Myocardial InfarctionIndication
Graft-Vs-Host DiseaseIndication
strokeClinical trial
The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled TrialStatus: Completed, Estimated PCD: 2022-06-09
Clinical trial
Safety and Efficacy Evaluation of Umbilical Cord Mesenchymal Stem Cells Transcatheter Transplantation to Treat Left Ventricular Dysfunction After Acute Myocardial InfarctionStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
Efficacy and Safety of UC-MSCS for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT: A Multicenter, Randomized, Open-label TrialStatus: Completed, Estimated PCD: 2022-05-30
Clinical trial
Outcomes of Umbilical Cord Blood-derived Mesenchymal Stem Cell Infusion in Patients With Neurological Complications After Ischemic StrokeStatus: Completed, Estimated PCD: 2022-12-30